Disposition of 3290 shares by James Polewaczyk of IDEXX Laboratories at 558.8822 subject to Rule 16b-3
| IDXX Stock | USD 421.75 0.01 0% |
Slightly above 56% of IDEXX Laboratories' investor base is looking to short. The analysis of overall sentiment of trading IDEXX Laboratories stock suggests that many investors are alarmed at this time. IDEXX Laboratories' investing sentiment can be driven by a variety of factors including economic data, IDEXX Laboratories' earnings reports, geopolitical events, and overall market trends.
IDEXX |
Filed transaction by IDEXX Laboratories Officer Executive Vice President. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
IDEXX Laboratories' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the IDEXX Laboratories' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
IDEXX Laboratories Historical Investor Sentiment
Investor biases related to IDEXX Laboratories' public news can be used to forecast risks associated with an investment in IDEXX. The trend in average sentiment can be used to explain how an investor holding IDEXX can time the market purely based on public headlines and social activities around IDEXX Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
IDEXX Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for IDEXX Laboratories and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average IDEXX Laboratories news discussions. The higher the estimate score, the more favorable the investor's outlook on IDEXX Laboratories.
IDEXX Laboratories Fundamental Analysis
We analyze IDEXX Laboratories' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of IDEXX Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of IDEXX Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
IDEXX Laboratories is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
IDEXX Laboratories Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IDEXX Laboratories stock to make a market-neutral strategy. Peer analysis of IDEXX Laboratories could also be used in its relative valuation, which is a method of valuing IDEXX Laboratories by comparing valuation metrics with similar companies.
Peers
IDEXX Laboratories Related Equities
| TWST | Twist Bioscience | 1.78 | ||||
| TMO | Thermo Fisher | 1.53 | ||||
| MTD | Mettler Toledo | 0.63 | ||||
| DHR | Danaher | 0.36 | ||||
| RVTY | Revvity | 0.08 | ||||
| A | Agilent Technologies | 0.12 | ||||
| ILMN | Illumina | 0.15 | ||||
| CRL | Charles River | 0.27 | ||||
| IQV | IQVIA Holdings | 0.29 | ||||
| WAT | Waters | 0.48 | ||||
| ICLR | ICON PLC | 1.22 |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.